Enhancing Therapeutic Efficacy: Pioneering Large-Scale Drug Pipeline Development and Testing on PKU Patients' iPSC-Derived Hepatocytes
Fields of Study & Subjects
Pluripotent Stem Cells Research
Drug-Induced Hepatotoxicity and Protection
Pharmacogenetics and Drug Metabolism
Publication details
- Journal / source
- Therapeutic Innovation Australia
- Publication date
- 17 February 2026
- Language
- EN